Why Is FibroGen (FGEN) Stock Down 81% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

FibroGen (FGEN) stock is heading lower on Monday after the company's Phase 3 clinical trial failed to meet its primary endpoint.

The post Why Is FibroGen (FGEN) Stock Down 81% Today? appeared first on InvestorPlace.

• Buy This $5 Stock BEFORE This Apple Project Goes Live
• Wall Street Titan: Here’s My #1 Stock for 2023
• The $1 Investment You MUST Take Advantage of Right Now
• It doesn’t matter if you have $500 or $5 million. Do this now.